Pharma

See the following -

3 Reasons Why Pharma mHealth Apps Have Failed

Jasmine Pennic | HIT Consultant | October 31, 2014

Pharma mHealth companies are struggling to have an impact on the mHealth app market generating only limited downloads and usage, despite releasing more than 100 pharma mHealth apps for iOS and Android...

Read More »

Clinovo White Papers Published In Summer 2014 Editions Of Leading Medical Device & Pharmaceutical Publications

Press Release | Clinovo | July 29, 2014

White papers by Clinovo on CDISC Standards for medical devices and cloud-based eClinical technologies have been published in the latest editions of leading pharmaceutical publications Data Basics and Med Device Online...

Read More »

Don't Trade Away Our Health

Joseph E. Stiglitz | The New York Times | January 30, 2015

A secretive group met behind closed doors in New York this week. What they decided may lead to higher drug prices for you and hundreds of millions around the world...

Read More »

Drug Industry: Open Data and Clinical Trials

Glyn Moody | ComputerWorld UK | November 21, 2012

Yesterday I was writing about open access and open data in the context of the EU's Horizon 2020 initiative. Closer to home, I came across a wonderful real-life example of how open data can almost certainly save not just money, but lives. Read More »

Harvard Law Conference Surveys Troubles With Health Care

Andy Oram | EMR & EHR | March 30, 2016

It is salubrious to stretch oneself and regularly attend a conference in a related field. At the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, one can bask in the wisdom of experts who are truly interdisciplinary (as opposed to people like me, who is simply undisciplined). Their Tenth Anniversary Conference drew about 120 participants. The many topics–which included effects of the Supreme Court rulings on the Affordable Care Act and other cases, reasons that accountable care and other efforts haven’t lowered costs, stresses on the pharmaceutical industry, and directions in FDA regulation–contained several insights for health IT professionals...

Read More »

Pharmaceutical and Biomedical Research using Agile Software

Andy Oram | EMR & EHR | January 18, 2016

Medical research should not be in a crisis. More people than ever before want its products, and have the money to pay for them. More people than ever want to work in the field as well, and they’re uncannily brilliant and creative. It should be a golden era. So the myriad of problems faced by this industry–sources of revenue slipping away from pharma companies, a shift of investment away from cutting-edge biomedical firms, prices of new drugs going through the roof–must lie with the development processes used in the industry...

Read More »

Recent Trends in Collaborative, Open Source Drug Discovery

Anuradha Roy, Peter R. McDonald and Rathnam Chaguturu | The Open Conference Proceedings Journal | October 30, 2011

In order to be more profitable and productive, the pharmaceutical industry has embraced an open innovation approach to share the drug discovery processes and data with academia.

Read More »